Treatment of a pediatric patient with MET-amplified signet ring cell adenocarcinoma of the stomach with crizotinib.

Sabree, Shakoora; Berg, Daniel; Sato, Mariko

Sabree, Shakoora; Berg, Daniel; Sato, Mariko.

Affiliation

Sabree S; Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Berg D; Department of Internal Medicine, University of Iowa Hospital and Clinics, Iowa City, Iowa.
Sato M; Department of Pediatric Hematology Oncology, Stead Family Children's Hospital, University of Iowa, Iowa City, Iowa.

Pediatr Blood Cancer ; 65(6): e26984, 2018 06.

Article in En | MEDLINE | ID: mdl-29380521

Subject(s)

Carcinoma, Signet Ring Cell/drug therapy; Crizotinib/therapeutic use; Gene Amplification; Proto-Oncogene Proteins c-met/genetics; Stomach Neoplasms/drug therapy; Adolescent; Carcinoma, Signet Ring Cell/genetics; Carcinoma, Signet Ring Cell/pathology; Humans; Male; Prognosis; Stomach Neoplasms/genetics; Stomach Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gene Amplification / Carcinoma, Signet Ring Cell / Proto-Oncogene Proteins c-met / Crizotinib Type of study: Prognostic_studies Limits: Adolescent / Humans / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google